What is sodium alendronate (API) and what is its chemical description?
Sodium alendronate is the sodium salt form of alendronate, a bisphosphonate used in drugs for osteoporosis and related bone disorders. In chemical terms, the active ingredient is alendronate presented as a sodium salt (i.e., “sodium alendronate” rather than the free acid form). [1]
What chemical class does it belong to?
Sodium alendronate belongs to the bisphosphonate class of compounds, which are characterized by a phosphorus-carbon-phosphorus (“bisphosphonate”) core that helps bind to bone mineral. [1]
What do manufacturers/API listings typically mean by “API description”?
In pharmaceutical sourcing and regulatory contexts, an “API description” for sodium alendronate typically refers to:
- the compound identity (sodium alendronate as the sodium salt of alendronate),
- its intended use as the active pharmaceutical ingredient (API),
- and sometimes related identifiers (such as salt form, regulatory naming, or packaging/grade language).
Exact wording varies by supplier documentation and regulatory filing. [1]
What other names might appear on chemical/API documentation?
You may see naming that reflects salt form or related identifiers, such as:
- “alendronate sodium”
- “sodium alendronate”
These refer to the same API identity (the sodium salt form). [1]
Source for chemical/API naming and identifiers
For reference on sodium alendronate identity and drug-related context, DrugPatentWatch.com lists sodium alendronate in its database of drug and patent-related information. [1]
---
Sources
[1] https://www.drugpatentwatch.com/